| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/21/2010 | EP2175728A1 Sodium channel inhibitors |
| 04/21/2010 | EP2175727A1 A crystalline synthetic intermediate for preparation of a dpp-iv inhibitor and method of purification thereof |
| 04/21/2010 | EP2175726A1 Compositions including androgen receptor degradation (ard) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss |
| 04/21/2010 | EP2175725A1 Quinazolinone t-type calcium channel antagonists |
| 04/21/2010 | EP2175722A2 Patient selection and therapeutic methods using markers of prostaglandin metabolism |
| 04/21/2010 | EP2041093B1 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases |
| 04/21/2010 | EP2029602B1 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases |
| 04/21/2010 | EP1963324B1 Heterocyclic compounds, their preparation and their use as antibacterials |
| 04/21/2010 | EP1910296B1 4-aryloxy quinoline derivatives as 5-ht6 modulators |
| 04/21/2010 | EP1909837B1 Compositions for treatment of systemic mastocytosis |
| 04/21/2010 | EP1901736B1 Pharmaceutical composition comprising simvastatin and ezetimibe |
| 04/21/2010 | EP1888584B1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity |
| 04/21/2010 | EP1887005B1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof |
| 04/21/2010 | EP1853270B1 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
| 04/21/2010 | EP1818329B1 (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2methyl-1,4homopiperazine hydrochloride dihydrate |
| 04/21/2010 | EP1811989B1 Preparation containing oxidized flavonoid derivatives |
| 04/21/2010 | EP1761494B1 Chemical compounds i |
| 04/21/2010 | EP1708790B1 Use of pipamperone and a d2-receptor antagonist or a serotonin/dopamin antagonist for the treatment of psychotic disorders |
| 04/21/2010 | EP1692206B1 Method of preparing carboxylic acid functionalized polymers |
| 04/21/2010 | EP1667732B1 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 04/21/2010 | EP1620082B1 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome |
| 04/21/2010 | EP1610780B1 Cyclic protein tyrosine kinase inhibitors |
| 04/21/2010 | EP1592388B1 Methods for diagnosis and monitoring of neurological disease by detection of an encephalotoxin |
| 04/21/2010 | EP1479670B1 Novel fused ring indazole compounds |
| 04/21/2010 | EP1471887B1 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 04/21/2010 | EP1442016B1 1h-indole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/21/2010 | EP1392256B1 Improved transdermal therapeutic system for the treatment of parkinson's disease |
| 04/21/2010 | EP1387685B1 Analgesic composition comprising an opioid and a sodium channel blocker |
| 04/21/2010 | EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists |
| 04/21/2010 | EP1268477B1 Substituted beta-carbolines with ikb-kinase inhibiting activity |
| 04/21/2010 | EP1258252B1 Integrin expression inhibitors |
| 04/21/2010 | EP1250328B2 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/21/2010 | EP0910369B1 Benzothiophenes, formulations containing same, and methods |
| 04/21/2010 | EP0888303B1 Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains |
| 04/21/2010 | EP0870033B1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 04/21/2010 | CN1978462B Imidazoline modified amino acid, and its synthesizing method and use for polypeptide marking |
| 04/21/2010 | CN1977852B Medicinal composition containing stilbene total glycoside and its use for pharmaceutical treating hepatitis B |
| 04/21/2010 | CN1965848B Lyophilized powder injection of breviscapinum and preparation process thereof |
| 04/21/2010 | CN1935812B Metal fullerol and its pharmaceutical use for inhibiting tumour growth |
| 04/21/2010 | CN1931269B Rutin containing medicine composition |
| 04/21/2010 | CN1927250B Pharmaceutical composition, its preparation method and application |
| 04/21/2010 | CN1923820B Novel carboxylic acid derivatives, their preparation and use |
| 04/21/2010 | CN1899283B Quality control method for medicinal composition containing artemisine |
| 04/21/2010 | CN1895354B Chinese-medicinal Bastian-Bruns agent for treating coronary heart disease and angina cordis and its making method |
| 04/21/2010 | CN1895340B Sobering-up composition |
| 04/21/2010 | CN1891296B Medicinal composition containing calcium agonist and phenoxy acid compound |
| 04/21/2010 | CN1878748B Process of hydrocyanation of unsaturated carboxylic acid derivatives |
| 04/21/2010 | CN1872297B Application of medication composition of Guangdong date in preparing medicine for treating chronic insufficiency of blood supply for brain |
| 04/21/2010 | CN1854134B Piperazine compounds, their preparation method and pharmaceutical composition containing same |
| 04/21/2010 | CN1819990B Compound having anti-HCV activity and process for producing the same |
| 04/21/2010 | CN1795195B Pyridopyrazines and the use thereof as kinase inhibitors |
| 04/21/2010 | CN1787810B Cladribine formulations for improved oral and transmucosal delivery |
| 04/21/2010 | CN1774460B Biodegradable polyurethane/urea compositions |
| 04/21/2010 | CN1761462B Patch containing nonsteroidal antiinflammatory and analgesic agent |
| 04/21/2010 | CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/21/2010 | CN1689628B Medical purpose of creat extract |
| 04/21/2010 | CN1662216B Skin conditioning compositions containing compounds for mimicking the effect on skin of retinoic acid |
| 04/21/2010 | CN1639318B Antimicrobial composition |
| 04/21/2010 | CN1522246B Triamide-substituted indoles, benzofuranes and benzothiophenes |
| 04/21/2010 | CN1514725B Pharmaceutical composition comprising lipase inhibitor and sucrose fatty acid ester |
| 04/21/2010 | CN1450890B Novel compositions of minoxidil |
| 04/21/2010 | CN1406123B Skin normalizing agents |
| 04/21/2010 | CN1343128B Medicinal compositions |
| 04/21/2010 | CN1248155B Compositions to control oral microbial oxidation-reduction (Eh) levels |
| 04/21/2010 | CN101696232A Peptidomimetic protease inhibitors |
| 04/21/2010 | CN101696229A Curcumin A as well as preparation method thereof and applications to preparing medicaments for treating cardiovascular and cerebrovascular diseases |
| 04/21/2010 | CN101696228A N-pyrazolyl glycosides derivatives as well as preparation method and application thereof |
| 04/21/2010 | CN101696208A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 04/21/2010 | CN101696205A 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition |
| 04/21/2010 | CN101696202A Phenylpropanoid compound contained in rhodiola, preparation method thereof and application thereof |
| 04/21/2010 | CN101696188A Trifluoromethyl substituted benzamides as kinase inhibitors |
| 04/21/2010 | CN101696183A (Z)-2-phenyl-3-(pyrrol-2-yl)-acrylonitrile derivative as well as salts, composition, preparation method and application thereof |
| 04/21/2010 | CN101696166A Preparation method for danshen root salvianolic acid A |
| 04/21/2010 | CN101696159A Method for extracting and separating eugenol, pharmaceutical composition containing eugenol and preparation method thereof |
| 04/21/2010 | CN101695575A Pharmaceutical composition containing statin-type lipid-lowering medicaments, phenformin-type hypoglycemic medicaments and nicotinic acid |
| 04/21/2010 | CN101695555A Medicament composition for treating prostatitis and prostatomegaly and preparation method thereof |
| 04/21/2010 | CN101695549A Chinese medicinal herb hemorrhoid comforting pill |
| 04/21/2010 | CN101695541A Composition for treating ischemic heart disease and preparation method thereof |
| 04/21/2010 | CN101695525A Chinese medicinal recovery mat, Chinese medicinal pillow and external application packet of health-care bag for preventing and treating various aches |
| 04/21/2010 | CN101695516A Immunostimulant for aquatic animals and preparation method thereof |
| 04/21/2010 | CN101695514A Traditional Chinese medicinal preparation for treating trauma and cicatricial hyperplasia gargalesthesia and preparation method thereof |
| 04/21/2010 | CN101695513A Composition with anti-tumor effect and application thereof |
| 04/21/2010 | CN101695503A Quality control method of pediatric paracetamol, atificial cow-bezoar and chlorphenamine maleate effervescent tablets |
| 04/21/2010 | CN101695499A Composite for killing fish ectoparasites and preparation method thereof |
| 04/21/2010 | CN101695498A Medicament for protecting hepatic injury caused by paracetanol and application thereof |
| 04/21/2010 | CN101695497A Injection medicament for treating chronic lymphoid thyreoitis |
| 04/21/2010 | CN101695496A Medicinal composition containing triflusal and clopidogrel |
| 04/21/2010 | CN101695495A Composition for treatment of external secretion disorders |
| 04/21/2010 | CN101695494A Composition of cefpriome sulfate and sodium citrate |
| 04/21/2010 | CN101695493A Composition of cefmetazole acid and sodium citrate |
| 04/21/2010 | CN101695492A Pharmaceutical composition containing statin-type lipid-lowering medicaments, sulphonylurea-type hypoglycemic medicaments and nicotinic acid |
| 04/21/2010 | CN101695491A Slow-release preparation of repaglinide |
| 04/21/2010 | CN101695490A Medicinal composition for treating livestock and poultry cold, preparation method thereof and application thereof |
| 04/21/2010 | CN101695489A Aztreonam composition, powder injection and preparation method thereof |
| 04/21/2010 | CN101695488A Compound articaine freeze-drying preparation for injection and preparation method thereof |
| 04/21/2010 | CN101695487A Polyenoic ethyl ester emulsion of high-purity EPA-E and DHA-E |
| 04/21/2010 | CN101695486A Use of chlorogenic acid in preparing medicament for treating marrow fibrillation |
| 04/21/2010 | CN101695485A Use of chlorogenic acid in preparing medicament for treating thrombocytopenia and anemia |
| 04/21/2010 | CN101695484A Use of chlorogenic acid in preparing medicament for treating marrow infection |
| 04/21/2010 | CN101695482A Glipizide orally disintegrating tablet and preparation process thereof |